Microplastics in the Brain: Is COVID-19 Making It Worse?
Table of Contents
Microplastics in the Brain: A Growing Concern
Emerging research has revealed a concerning trend: microplastics—tiny plastic particles less than 5 millimeters in size—are accumulating in human brain tissue at significantly higher levels than previously recorded. A 2025 study published in Nature Medicine found that microplastic concentrations in the brain increased by approximately 50 % between 2016 and 2024, with levels in brain tissue surpassing those in other organs like the liver and kidneys [1].
Concurrently, studies have shown that COVID-19 can compromise the integrity of the blood–brain barrier (BBB), the brain’s protective shield against harmful substances. Research indicates that both acute COVID-19 infections and long-COVID cases with cognitive impairments exhibit signs of BBB disruption, potentially allowing foreign particles, including microplastics, to infiltrate brain tissue [9].
This article explores emerging evidence linking increased microplastic accumulation in the brain with the physiological impacts of COVID-19. We will explore how microplastics enter the brain, the role of COVID-19 in potentially facilitating this process, and the implications for neurological health. Finally, we will discuss recent findings from 2024–2025 and consider measures to protect public health against this growing concern.
Not long ago, the notion that microplastics—fragments of plastic less than 5 mm, including nanoscale particles—could end up in the human brain might have sounded far-fetched. But recent studies have turned this concern into reality [3]. In early 2025, researchers reported alarmingly high concentrations of microplastic particles in post-mortem human brain samples, with levels rising over time. In brain tissue collected from people who died in 2024, the median concentration of plastic was nearly 5,000 µg per gram of brain tissue—almost 0.5 % of the brain’s weight was plastic [2]. This total was about 50 % higher than that found in brains from 2016, suggesting a rapid increase in brain microplastic burden paralleling the explosion of microplastics in our environment. Get monthly clean-air science updates—join our list here.
Equally unsettling was the discovery that dementia patients’ brains harbored even more microplastics. In that study, researchers analyzed a dozen brains from individuals who had died with various dementias, including Alzheimer’s disease. These dementia-afflicted brains contained on average three to six times more plastic by weight than the brains of people without dementia [2]. While this correlation is not proof that microplastics cause cognitive decline, it raises red flags. Impaired clearance mechanisms and BBB integrity are hallmarks of neurodegenerative disease and could allow more debris (like microplastics) to accumulate [1]. In other words, it may be that a diseased brain is less able to purge or block these particles—but the question remains: could those plastics also be contributing to the damage?
“The evidence here is concerning,” noted ecotoxicologist Bethanie Carney Almroth, commenting on the 2025 findings [2].
Tiny plastic particles were found in every single human brain sample the researchers examined. This means that at least some microplastics are somehow crossing into the brain, an organ normally safeguarded by multiple protective layers. Almroth remarked that when it comes to microplastics, “the blood-brain barrier is not as protective as we’d like to think.” Some of the plastic bits detected in brain tissue appeared larger than what should be able to cross from blood to brain, “yet there they are,” she said. Most of the brain-invading particles were nanoplastics—smaller than a micron—particularly fragments of polyethylene (from common materials like plastic bags and food packaging) [2]. Such minuscule size likely aids their infiltration. But the presence of a few larger fragments hints at unknown pathways or a breakdown of barriers that normally keep foreign particles out.
What does it mean that our brains are accumulating plastic? The truth is, we don’t fully know yet, but scientists are increasingly worried. Microplastics have already been detected throughout the human body—in blood, lungs, placentas, and even breast milk. Now that brain tissue is confirmed to be a repository of these pollutants, researchers are racing to understand the implications. One immediate concern is that microplastics might induce inflammation or toxicity in brain cells. Another is that they could interfere with the delicate neuronal networks, either by physically blocking tiny blood vessels or by carrying toxic chemicals into the brain. As we’ll see, initial studies are finding hints of all these effects. But how are these plastic intruders even getting into the brain in the first place?
Breaching the Barrier: How Microplastics Enter the Brain
The human brain is protected by the blood–brain barrier (BBB) – a fortress-like lining of specialized cells that strictly controls what can pass from circulating blood into the brain’s central nervous system. Normally, pathogens, large molecules, and toxins are kept out, while oxygen and nutrients are let in. Breaching the BBB is no easy feat; even many medications cannot cross it. Yet microplastics, it appears, are managing to slip through the cracks. Understanding how they do this is key to addressing the risk.
One obvious route is via the bloodstream. If tiny plastic particles enter our circulation (through ingestion or inhalation), they may be carried to the brain’s capillaries. Under normal conditions, capillary walls (comprised of BBB endothelial cells) would filter out such debris. Nanoscale plastics, however, are so small that they can penetrate the BBB and enter brain tissue directly. Laboratory experiments support this: in animal studies, micro- and nanoplastics introduced into the bloodstream have been seen to lodge in the brain. A 2025 study in Science Advances visualized how some circulating microplastics get “phagocytosed” (engulfed) by immune cells which then travel into brain capillaries and become stuck, causing blockages. In mice, these microplastic-induced microvascular clots led to reduced cerebral blood flow and noticeable neurological abnormalities [8].
Another path into the brain is through the olfactory nerve in the nose. This route bypasses the BBB entirely. The olfactory nerves that enable our sense of smell provide a direct conduit from the nasal cavity to the brain’s olfactory bulb [5]. It’s a known loophole that certain viruses, and even amoebae, can occasionally exploit. Recent evidence suggests microplastics might also use this backdoor. In 2024, researchers reported finding microplastics in the olfactory bulbs of human cadavers. They examined autopsy samples from 15 individuals and detected plastic fragments in the olfactory brain region of eight of them. A total of 16 plastic particles were identified, including fibers of polypropylene, polyamide (nylon), and polyethylene-vinyl acetate – materials common in fabrics, furnishings, and packaging. These bits were much smaller than those found in other organs like lung or liver, aligning with the idea that only very fine particles can penetrate that far. The study’s authors noted that the nose normally traps a lot of inhaled dust and particles – it’s essentially the body’s air filter. Some of those particles get stuck in the mucus and tissues of the nasal cavity. If they are tiny enough (or if the nasal lining is inflamed and “leaky”), they could migrate along the olfactory nerves. Indeed, scientists speculated that nasal inflammation might make it easier for microplastics to enter the tissue and reach the olfactory bulbs [4].
Importantly, not all microplastics will reach the brain – size matters. Particles larger than a certain threshold (on the order of a few microns) are generally too big to pass through cellular barriers. Those might remain stuck in nasal passages, lungs, or gut. But the smallest of the small, nanoplastics, pose the greatest threat of translocation. In the autopsy study, the plastics in the olfactory bulb were predominantly in the tens-of-microns down to sub-micron range [4]. And as mentioned, the Nature Medicine study found polyethylene fragments under 1 µm wide throughout cortical brain tissue [1].
Laboratory research backs up these human findings. In a 2023 experiment, University of Rhode Island scientists exposed mice to microplastics in drinking water to see if the particles would reach the brain. After just three weeks of daily exposure, they found microscopic plastic beads had crossed the BBB and lodged deep in the mice’s brain tissue. “We were very surprised to see that,” said lead researcher Jaime Ross, noting that the BBB is supposed to block such invaders. But under the microscope, there it was: clear evidence of fluorescent-tagged microplastic particles scattered in the brain [7].
How did the plastics get there? The mice were exposed via drinking water, suggesting the particles traveled from gut to bloodstream to brain. It’s likely that in humans, ingestion and inhalation are both relevant exposure routes. We consume microplastics in food and water and inhale them from dust and air pollution. Once in our body, some fraction enters the blood. A recent estimate found the average person’s bloodstream contains dozens of microplastic particles per milliliter of blood [8]. From the blood, as we’ve seen, the tiniest fragments may work their way across the BBB or hitch a ride on transporter cells. Additionally, damage to barrier integrity (from inflammation, disease, or even normal aging) can create larger openings. The stage is set such that if something weakens our brain’s defenses, microplastics could exploit the breach. Unfortunately, one widespread event known to compromise the BBB is COVID-19 infection. Let’s examine how COVID affects the blood–brain barrier and brain health, and why that could worsen the microplastic infiltration problem. See real-time research threads and mitigation tips—follow us on X, Instagram & LinkedIn.
COVID-19’s Collateral Damage: A Leaky Blood-Brain Barrier
SARS-CoV-2 (the virus causing COVID-19) is primarily a respiratory pathogen, but its effects are far from confined to the lungs. Early in the pandemic, patients and doctors were perplexed by the neurological symptoms that many COVID sufferers experienced: loss of smell, headaches, confusion, strokes, and the persistent cognitive sluggishness now dubbed “brain fog” in long COVID. Researchers soon zeroed in on the blood–brain barrier as a potential casualty of COVID’s rampage.
In a healthy state, the BBB’s tightly joined cells keep most pathogens and toxins out of the brain. But COVID-19 triggers a storm of inflammation and circulatory changes that can disrupt the BBB’s integrity. A groundbreaking study published in Nature Neuroscience in 2024 provided concrete evidence of this BBB damage. Using advanced MRI imaging, scientists showed that during acute COVID infection – and even months later in some long-COVID patients – the BBB becomes abnormally permeable. Patients with long COVID who were suffering cognitive impairment (“brain fog”) had clear signs of BBB leakage on their scans [9]. Their blood carried biomarkers indicating that the normally tight barrier was compromised.
What causes the BBB to open up during COVID? Part of the answer may lie in inflammation. The infection provokes a systemic inflammatory response that affects blood vessels throughout the body. In the brain’s vasculature, inflammatory signals can loosen the tight junctions between cells or even damage the cells directly. The Nature Neuroscience study found that long-COVID patients with cognitive issues had sustained systemic inflammation and elevated inflammatory markers that correlated with BBB disruption. Moreover, when researchers took blood serum from long-COVID patients and applied it to cultured human brain endothelial cells (the kind that form the BBB), the cells began expressing inflammation-related genes – essentially, the patients’ blood was inducing barrier cells to become inflamed and leaky.
Another factor is the immune dysregulation brought on by COVID. Normally, the BBB also relies on support from astrocytes and other brain cells, as well as a well-regulated immune response to maintain its integrity. The 2024 study noted a “dampened adaptive immune response” in patients with long-COVID brain fog.
Indeed, the researchers concluded that persistent BBB dysfunction is a “key feature” of long COVID in those with neurological symptoms [9]. Even after the acute illness, something akin to a smoldering fire remains: chronic inflammation and incomplete repair of the vascular damage. Other studies echo these findings. Biomarkers of BBB damage (like fragments of barrier proteins) have been found circulating at higher levels in people after COVID infection. Autopsies of patients who died of COVID often reveal microscopic damage in the brain’s blood vessels – inflammation in the vessel walls, clots, and leaky spots where blood cells spilled into brain tissue [10].
COVID-19 can also indirectly batter the BBB through microclot formation. It’s well known that SARS-CoV-2 infection can cause abnormal blood clotting. Tiny clots (microthrombi) have been detected in the brains of those who suffered severe COVID, contributing to strokes and neurological injury [11]. New research suggests that these microclots might underlie long-COVID brain fog as well. For instance, a 2023 study found that elevated levels of certain clotting proteins (like fibrinogen and D-dimer) during acute COVID were associated with cognitive problems months later [12]. The hypothesis is that even microclots which don’t cause obvious strokes could chronically impair brain capillaries, leading to low-grade oxygen deprivation or BBB stress. Clots can physically damage the BBB, and when they eventually break down, the by-products (like D-dimer fragments) indicate that clotting and subsequent vessel leakiness occurred [12].
In summary, COVID-19 – especially in its long-term aftermath – can leave the blood–brain barrier “ajar.” During this window of vulnerability, substances that are usually kept out of the brain may gain entry. Think of the BBB like a sieve that normally has super-fine mesh; COVID punches larger holes in it. And this is where microplastics come into play. If a person has microplastic particles circulating in their blood (which, as noted, most of us likely do to some extent), a COVID-compromised BBB could let more of those particles slip into the brain than would otherwise be possible. The damaged barrier might also impair the brain’s ability to clear out intruders. The brain does have mechanisms to remove waste, such as the glymphatic system and immune cells like microglia that can engulf foreign matter. But a virus-triggered immune dysfunction might reduce the efficiency of these cleanup crews. We now turn to the effects that both COVID and microplastics have on the brain – and what happens when the two collide.
COVID-19’s Impact on the Brain
Beyond the BBB, COVID-19 has a host of direct and indirect effects on the brain. Many COVID patients – even some with “mild” illness – report neurological symptoms during or after infection. Short-term effects of acute COVID can include loss of smell (anosmia), headaches, delirium, and stroke. The loss of smell is thought to result from the virus infecting cells in the nasal cavity and possibly the olfactory nerve; some evidence even found viral RNA in the olfactory bulbs of patients, indicating the virus itself might occasionally enter the brain. Stroke and acute confusion in severe COVID cases are often linked to the intense inflammation and coagulation issues we discussed, which can cause brain tissue damage.
It is long COVID, however, that has shone a spotlight on COVID’s capacity for lasting neurological harm. Studies estimate that around 10–20 % of those infected experience prolonged symptoms, and among the most common is “brain fog” – a constellation of memory lapses, difficulty concentrating, slow or fuzzy thinking, and mental fatigue.
Research is now confirming that these cognitive complaints often correspond to measurable deficits. For example, one study found that even mild COVID infections can lead to cognitive impairments equivalent to a decline of a few IQ points, detectable months later. Another long-term study of COVID survivors who had been hospitalized showed significant issues with attention, executive function, and memory up to two years post-infection [19]. In one cohort, a startling 95 % of long-COVID patients reported cognitive changes months after illness [20]. “In coastal communities with higher levels of microplastics in the water, there were higher rates of disabilities that can affect…thinking and memory,” the study’s co-author reported [13].
The mechanisms behind these lingering effects are still being unraveled, but a few leading theories have emerged (and they aren’t mutually exclusive):
- Chronic inflammation and immune dysregulation: As noted, long-COVID patients often have signs of ongoing inflammation. This can lead to a neuroinflammatory state – essentially, the brain’s immune cells (microglia) become activated and start producing cytokines that alter neuronal function. Chronic neuroinflammation is a known pathway to cognitive impairment in other conditions, too.
- Microvascular damage: Those microclots and vascular injuries can kill or impair small networks of neurons by robbing them of oxygen and nutrients. Even if patients don’t experience a noticeable stroke, widespread microvascular disturbances could produce subtle cognitive deficits and “fog.”
- Direct viral effects or persistence: There’s debate about whether the virus (or viral fragments) persist in some people’s bodies and brains, continuing to provoke immune reactions. Some autopsy studies have found viral proteins in brain tissue weeks after infection, although widespread brain infection by SARS-CoV-2 is not typically seen. However, even transient infection of the lining of blood vessels or support cells could set off a cascade that has lasting impact.
- Autoimmune reactions: Another hypothesis is that COVID triggers the development of autoantibodies that attack the patient’s own nervous system, as happens in some other post-viral syndromes. This could cause inflammation or damage in brain tissue, leading to cognitive symptoms.
COVID’s neurological impact has even drawn comparisons to neurodegenerative diseases. The cognitive profile of some long-COVID patients – memory and attention problems – resembles early dementia, and imaging studies have noted brain atrophy (shrinkage) in certain regions after COVID, akin to changes seen in aging [20]. To be clear, COVID is not known to cause Alzheimer’s or Parkinson’s outright. But the parallels in inflammation and BBB breakdown have researchers concerned that severe or repeated COVID infections might accelerate neurodegenerative processes in some individuals. One alarming study in the UK found that people who had COVID showed greater brain tissue loss in areas related to smell and cognition compared to those who never had COVID, even after mild cases – though long-term follow-up is needed to see if those changes persist or translate into higher dementia risk [20].
In short, COVID-19’s toll on the brain can range from acute, reversible effects to prolonged cognitive impairment. “Brain fog” is not just an anecdote; it’s being backed up by neuropsychological tests and biomarkers. This matters greatly for our topic because if COVID leaves a brain vulnerable – via a leaky BBB, inflamed milieu, or impaired repair mechanisms – it could pave the way for other environmental insults to have an outsized effect. A growing concern is the infiltration of microplastics—an issue the next section explores in depth.
Microplastics and Brain Health
What happens when microplastics actually take up residence in the brain? The research here is in early stages, but initial findings point to potentially serious consequences. While we do not yet have longitudinal studies in humans linking brain microplastics to specific neurological diseases, animal studies and cellular experiments are sounding alarms. In parallel, some epidemiological clues in humans hint that microplastic exposure could be associated with cognitive decline.
One line of evidence comes from laboratory rodent studies. Recall the URI experiment where mice were given microplastics in their drinking water to see if the particles would reach the brain. After just three weeks of daily exposure, they found microscopic plastic beads had crossed the BBB and lodged deep in the mice’s brain tissue. The young mice exposed to microplastics began to show memory and learning impairments and exhibited behaviors analogous to human dementia symptoms. This was striking given the short exposure duration.
Additionally, when the scientists examined the mice’s brain tissue, they found signs of molecular changes. Notably, levels of a protein called GFAP (glial fibrillary acidic protein) were markedly decreased in exposed mice. GFAP is an important structural protein in astrocytes (support cells in the brain), and a drop in GFAP has been observed in early stages of neurodegenerative disorders and in brain trauma. The fact that microplastics could alter GFAP in young healthy mice raised red flags that these particles were inducing a kind of accelerated aging or degeneration in the brain [7]. The researchers easo noted an inflammatory response: microglial cells (the brain’s immune cells) were activated in the presence of microplastics [6].
Other animal studies have reported similar findings. For example, mice exposed to polystyrene nanoplastics developed memory deficits and anxiety-like behaviors, along with evidence of oxidative stress and synaptic loss in the brain [6]. Nanoplastics have been shown to trigger inflammation in the brain and even interact with proteins like alpha-synuclein, which is implicated in Parkinson’s disease, potentially exacerbating neurodegenerative processes [8]. In fish and other marine animals, microplastic exposure has led to altered behavior and brain chemistry, suggesting a conserved effect across species: these particles are neurotoxic [6].
We should note that dose and duration are critical – many of these studies use exposure levels that are high to simulate lifetime or environmental extremes in a short time. However, as one toxicology adage goes, “the dose makes the poison.” The worrying aspect is that we are all accumulating dose over time simply by living in a world saturated with microplastics. And those rodent studies indicate that even moderate, short-term doses can cause measurable brain changes.
What about humans? Direct evidence linking microplastics to cognitive decline in people is only beginning to emerge. One intriguing epidemiological study was presented in 2025 at the American Academy of Neurology. Researchers looked at communities in the U.S. with varying levels of microplastic pollution in coastal waters (as a proxy for environmental microplastics exposure). They found that counties with the highest concentrations of marine microplastics had significantly higher rates of cognitive and neurological disability among residents, compared to counties with cleaner water. Even after adjusting for confounding factors, the areas with very high microplastic levels showed about a 9 % higher prevalence of cognitive impairment and problems with independent living activities [13].
Furthermore, the Nature Medicine study found six-fold higher microplastic levels in the brains of dementia patients than in those without dementia 2. The authors cautiously noted that dementia itself could allow plastics to accumulate (due to BBB breakdown and poor clearance) [1]. But they could not rule out that the plastics might also be contributing to neurodegeneration. It’s a classic chicken-and-egg dilemma that ongoing research will need to untangle. Regardless, the association strengthens the plausibility that microplastics in the brain are not benign bystanders.
Mechanistically, scientists are exploring how microplastics might harm brain cells. Several potential pathways have been identified:
- Chronic inflammation: Microplastics may act as irritants. When microglia attempt to digest these foreign particles, they can become hyper-activated, secreting inflammatory cytokines. Chronic microglial activation can lead to neuroinflammation, which over time damages neurons and synapses [6] [8].
- Oxidative stress: The surfaces of microplastics can carry reactive chemicals or metals, or even generate reactive oxygen species. This can cause oxidative stress in neurons – essentially “rusting” cells at the molecular level – leading to cell injury or death [6].
- Physical blockage and injury: Microplastics can block tiny blood vessels [8]. They might also lodge in neural tissue and disrupt the physical architecture, potentially “scratching” or puncturing cells from the inside [6].
- Protein aggregation: Early research hints that nanoplastics might promote the aggregation of misfolded proteins in the brain (like amyloid or alpha-synuclein) [8]. If true, that could accelerate diseases such as Alzheimer’s or Parkinson’s.
- Carrying toxicants: Plastics often adsorb other environmental toxins (like heavy metals or organic pollutants). When microplastics enter the body, they could act as Trojan horses, releasing these chemicals in sensitive organs including the brain, compounding toxicity [21].
Given these potential harms, microplastics in the brain start to look less like innocent hitchhikers and more like potential agents of neurological disease. It may not be a coincidence that microplastic pollution has exponentially increased in the last few decades – and over that same time, we’ve seen rising trends in certain neurodevelopmental and neurodegenerative conditions (though many factors are at play). The critical question this article poses is: Could COVID-19 be accelerating our brain’s microplastic burden and its consequences? We’ve seen how COVID can weaken the BBB and stir up inflammation. We’ve now seen what microplastics might do once in the brain. The stage is set to consider their combined, synergistic impact.
When Viruses and Pollutants Collide: A Synergistic Threat
It’s an unfortunate convergence: a pandemic virus that leaves lingering damage in its wake, and a pollutant that’s infiltrating every corner of our bodies. The hypothesis that COVID-19 could worsen microplastic accumulation in the brain is grounded in several overlapping aspects of pathology:
Blood–Brain Barrier Breaches. Perhaps the most straightforward link is that COVID-induced BBB disruption provides an opportunity for microplastics to enter the brain more freely. If someone contracted COVID and their BBB became leaky for weeks or months, any microplastics circulating in their blood during that period might penetrate in greater numbers. Over repeated infections or a long bout of long COVID, this could significantly increase the brain’s plastic load. Researchers have observed that other conditions involving BBB impairment (like strokes or autoimmune encephalitis) can lead to increased uptake of substances into the brain [1]. COVID’s effect might be similar—effectively lowering the drawbridge for microscopic intruders.
Impaired Clearance and Immune Defense. The immune dysregulation caused by COVID could reduce the brain’s ability to cope with and clear foreign particles. Under normal conditions, if a few microplastics get into the brain, phagocytes (including microglia) can often clean them up. But COVID has been shown to dampen aspects of the adaptive immune response and alter microglial function [9]. Long-COVID patients, for example, show signs of an “exhausted” immune profile—meaning intruders that reach the brain may “stick around” longer and do more harm.
Microvascular Complications. Both COVID-19 and microplastics have been implicated in microvascular dysfunction, and together they could have an additive or synergistic effect. Microplastics in blood can obstruct brain capillaries [8]. COVID infection, especially in severe cases, also causes microvascular inflammation and microclots [11]. In combination, blockages plus inflammation could amplify hypoxia and BBB stress.
Amplified Neuroinflammation. COVID and microplastics independently provoke brain inflammation. Together, they might ratchet neuroinflammation to particularly damaging levels—COVID primes microglia; microplastics supply the foreign bodies that keep them over-activated.
Shared Vulnerable Populations. Communities with high particulate pollution (and thus higher microplastic exposure) often also face elevated COVID burden and limited healthcare resources. The two threats could therefore converge on the same groups, widening existing health disparities.
While this synergistic threat is still a hypothesis, its plausibility is underscored by parallels in other domains: air pollution worsens respiratory viral infections [16]; viruses weaken mucosal barriers and set the stage for secondary bacterial disease; and so on. Early animal work and clinical observations already support many of the individual links in the chain. The coming section highlights some new discoveries from 2024–2025 that are moving our understanding forward.
New Evidence from 2024–2025
New population-scale studies sharpen the picture of how plastic pollution, dirty air, and SARS-CoV-2 interact. In U.S. coastal counties burdened with the highest marine-microplastic loads, researchers have documented significantly elevated rates of cognitive and functional disability among residents [14]. Cardiologists, meanwhile, have traced nanoplastic fragments inside arterial plaque and linked their presence to higher risks of atherosclerosis and heart disease [15], extending microplastics’ reach well beyond the brain. Toxicologists add that the same inhalable particulates—plastic or otherwise—can blunt antiviral immunity and amplify respiratory infections [18]; during the COVID-19 pandemic, a landmark Harvard analysis showed that each incremental rise in PM₂.₅ correlated with greater county-level mortality [16]. The World Health Organization’s 2022 update now labels air pollution “one of the greatest environmental threats to health,” warning that its vascular and immune effects compound other hazards [17]. Together, these strands of evidence reveal a converging threat: airborne microplastics, legacy air pollutants, and pandemic viruses are acting on overlapping pathways—compromising vascular integrity, stoking inflammation, and weakening immunity—and in doing so, they magnify one another’s damage.
Conclusion: Protecting the Brain from Invisible Intruders
The evidence is increasingly clear: our brains are not as insulated from the outside world as we once thought. Tiny plastic particles born of our industrial society are breaching defenses and taking up residence in the very tissue that makes us who we are—and a virus that has infected hundreds of millions might be holding the door open.
From a public-health perspective, several actionable strategies emerge:
- Reduce microplastic pollution at the source. Policies that curb single-use plastics and improve waste management will lower environmental microplastics and, in turn, internal exposure.
- Improve indoor air quality and filtration. High-efficiency (HEPA) filtration captures airborne particulates—including microplastics—and simultaneously reduces respiratory-virus transmission.[22]
- Address COVID-19 as an ongoing risk. Preventing repeat infections preserves BBB integrity; masking, ventilation, next-generation vaccines, and antivirals all play a role.
- Surveillance of neurodevelopment and neurodegeneration. Monitor cognitive function in highly exposed cohorts and long-COVID patients; track pollutant loads alongside neurological outcomes.
- Public education. Invisible does not mean harmless. Communicating that an average brain may already contain a spoonful of microplastics [2] can galvanize support for pollution-control measures.
Ultimately, safeguarding the blood-brain barrier and reducing our personal microplastic burden are two sides of the same public-health coin. By preventing repeat SARS-CoV-2 infections, cleaning the air we breathe, and shrinking the global torrent of disposable plastic, we can blunt the synergistic threat these invisible intruders pose to our brains. The science is still unfolding, but the precautionary steps are already clear—invest in clean ventilation and filtration, support policies that curb plastic pollution, and treat COVID-19 mitigation as a long-term brain-health strategy.
Fuel open-source clean-air research—make your tax-deductible gift today here.
"The most alarming of all man’s assaults upon the environment is the contamination of air, earth, rivers, and sea with dangerous and even lethal materials."
- Nihart, A. J., Garcia, M. A., El Hayek, E. et al. “Bioaccumulation of microplastics in decedent human brains.” Nature Medicine 31 (2025): 1114-1119. DOI 10.1038/s41591-024-03453-1. https://www.nature.com/articles/s41591-024-03453-1
- Main, D. “High levels of microplastics found in human brains.” The New Lede, 3 Feb 2025. https://www.thenewlede.org/2025/02/microplastics-found-in-human-brains-in-high-levels
- Spichak, S. “Rising Microplastic Levels in the Brain: A Growing Concern.” Being Patient, 19 Feb 2025. https://www.beingpatient.com/rising-microplastic-levels-in-the-brain-a-growing-concern
- Amato-Lourenço, L. F. et al. “Microplastics in the Olfactory Bulb of the Human Brain.” JAMA Network Open 7 (2024): e2337126. DOI 10.1001/jamanetworkopen.2024.40018. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2823787
- Kuta, S. “Scientists Find Microplastics in Human Brain Tissue Above the Nose.” Smithsonian Magazine, 18 Sep 2024. https://www.smithsonianmag.com/smart-news/scientists-find-microplastics-in-human-brain-tissue-above-the-nose-180985100/
- Gaspar, L., Bartman, S., Coppotelli, G., Ross, J. M. “Acute Exposure to Microplastics Induced Changes in Behavior and Inflammation in Young and Old Mice.” International Journal of Molecular Sciences 24 (2023): 12308. DOI 10.3390/ijms241512308. https://www.mdpi.com/1422-0067/24/15/12308
- University of Rhode Island, Ryan Institute. “A new study investigates the impact of microplastics in the brain.” Press release, 4 Aug 2023. https://ryaninstitute.uri.edu/microplastics/
- Zhou, B. et al. “Microplastics in the bloodstream can induce cerebral thrombosis by causing cell obstruction and lead to neurobehavioral abnormalities.” Science Advances 11 (2025): eadr8243. DOI 10.1126/sciadv.adr8243. https://www.science.org/doi/10.1126/sciadv.adr8243
- Greene, C. et al. “Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.” Nature Neuroscience 27 (2024): 421-432. DOI 10.1038/s41593-024-01576-9. https://www.nature.com/articles/s41593-024-01576-9
- Wallensten, J. et al. “One-year longitudinal study on biomarkers of blood–brain barrier permeability in COVID-19 patients.” Scientific Reports 14 (2024): 22735. DOI 10.1038/s41598-024-73321-y. https://www.nature.com/articles/s41598-024-73321-y
- Xie, Y. et al. “Mechanisms of neurological manifestations of COVID-19.” Nature Reviews Neuroscience 24 (2023): 565-584. DOI 10.1038/s41583-023-00744-4. https://doi.org/10.1038/s41583-023-00744-4
- Reardon, S. “Blood Clotting Proteins Might Help Predict Long COVID Brain Fog.” Scientific American, 6 Oct 2023. https://www.scientificamerican.com/article/blood-clotting-proteins-might-help-predict-long-covid-brain-fog/
- Desai, B. et al. “Marine Microplastic Pollution and Neurologic Disability in Coastal Communities.” Abstract, AAN Annual Meeting 2025. https://www.neurologyadvisor.com/reports/marine-microplastic-pollution-and-neurologic-disability-whats-the-link/
- Ganatra, S. “Microplastics in ocean linked to disabilities for coastal residents.” American Academy of Neurology press release, 25 Feb 2025. https://www.aan.com/PressRoom/Home/PressRelease/5236
- Haelle, T. “Microplastic particles linked to heart disease.” National Geographic, Apr 2024. https://www.nationalgeographic.com/premium/article/microplastics-plaque-heart-disease
- Harvard T. H. Chan School of Public Health. “Air pollution linked with higher COVID-19 death rates.” Press release, 7 Apr 2020. https://www.hsph.harvard.edu/news/multitaxo/topic/air-pollution/10/
- World Health Organization. Air Pollution and Health: Summary. 2022 update. https://cdn.who.int/media/docs/default-source/environmental-health-impact/who_compendium_air_pollution_01042022_eo_final.pdf
- Gowdy, K. et al. “Air pollution and respiratory infections: the past, present, and future.” Toxicological Sciences 191 (2023): 1-15. DOI 10.1093/toxsci/kfad005. https://academic.oup.com/toxsci/article/192/1/3/6978214
- Taquet, M. et al. “Incidence of neurological and psychiatric sequelae 6 months after COVID-19.” The Lancet Psychiatry 8 (2022): 416-427. DOI 10.1016/S2215-0366(21)00084-5. https://doi.org/10.1016/S2215-0366(21)00084-5
- Douaud, G. et al. “SARS-CoV-2 is associated with changes in brain structure in UK Biobank.” Nature 604 (2022): 697-707. DOI 10.1038/s41586-022-04569-5. https://doi.org/10.1038/s41586-022-04569-5
- Helmholtz-Zentrum Hereon. “Microplastics: A Trojan Horse for Metals.” ScienceDaily, 9 Aug 2021. https://www.sciencedaily.com/releases/2021/08/210809144107.htm
- Carrington, D. “HEPA air filters capture airborne microplastics – and protect against viruses.” The Guardian, 13 Nov 2023. https://www.theguardian.com/environment/2023/nov/13/hepa-air-filters-capture-airborne-microplastics-and-protect-against-viruses
Sarah Masih, MD, MBA
Sarah Masih is the Executive Director of Air Support Project and has extensive experience in project management, fundraising, and communications. Her deep commitment to public health and her collaborative approach with community organizations and health experts make her a vital force in the fight for cleaner air and healthier communities.
S. Riley
S. Riley is a mutlidisciplinary content creator and technology enthusiast with a background in crowdfunding and project management. He holds a BA in English, and is grateful to be able to utilize his unique skill set in service of Air Support Project's humanitarian mission.
what's in the air we breathe?
On average, we breathe 6 liters every minute, mainly indoors. Indoor air quality is often worse than outdoor air which underscores our need for cleaner air and safer spaces. Our air is made up of microparticles such as dust, pollen, mold, viruses, pet dander, and VOCs. These particles can enter our bloodstream through our lungs after we inhale them. The air we breathe impacts our daily and long-term well-being and health. Follow us at Air Support Project. We want you to know better so you can breathe better.